Wen Wei

917 total citations
21 papers, 551 citations indexed

About

Wen Wei is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Wen Wei has authored 21 papers receiving a total of 551 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 7 papers in Cancer Research and 6 papers in Molecular Biology. Recurrent topics in Wen Wei's work include Breast Cancer Treatment Studies (6 papers), HER2/EGFR in Cancer Research (3 papers) and Cancer Risks and Factors (2 papers). Wen Wei is often cited by papers focused on Breast Cancer Treatment Studies (6 papers), HER2/EGFR in Cancer Research (3 papers) and Cancer Risks and Factors (2 papers). Wen Wei collaborates with scholars based in China and Taiwan. Wen Wei's co-authors include Shan Zhu, Juanjuan Li, Shengrong Sun, Chuang Chen, Qi Wu, Juan Wu, Yimin Zhang, Qian Liu, Yi Tu and Chuang Chen and has published in prestigious journals such as IEEE Transactions on Biomedical Engineering, Oncotarget and Oxidative Medicine and Cellular Longevity.

In The Last Decade

Wen Wei

21 papers receiving 545 citations

Peers

Wen Wei
Comparison fields: 5 of 77
  • Oncology 262
  • Cancer Research 202
  • Molecular Biology 166
  • Pulmonary and Respiratory Medicine 111
  • Radiology, Nuclear Medicine and Imaging 86
F. De Vita Italy
Tessa G. Steenbruggen Netherlands
Samanta Sarti Italy
Wenbin Huang China
Michiko Imamura Japan
Christine Gennigens Belgium
Marco Puzzoni Italy
Alexander Meisel Switzerland
F. De Vita Italy View profile →
Citations per field, relative to Wen Wei
Wen Wei · 1×
Citations per year, relative to Wen Wei
Wen Wei · 1×

Countries citing papers authored by Wen Wei

Since Specialization
Citations

This map shows the geographic impact of Wen Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wen Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wen Wei more than expected).

Fields of papers citing papers by Wen Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wen Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wen Wei. The network helps show where Wen Wei may publish in the future.

Co-authorship network of co-authors of Wen Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Wen Wei. A scholar is included among the top collaborators of Wen Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wen Wei. Wen Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Title Journal Authors Indexed citations
1 Identification of UCP1 and UCP2 as Potential Prognostic Markers in Breast Cancer: A Study Based on Immunohistochemical Analysis and Bioinformatics Frontiers in Cell and Developmental Biology Xin Yu, Qi Wu et al. 15
2 Low CRIM1 Levels Predict Poor Prognosis in Breast Cancer Patients Frontiers in Oncology Wen Wei, Liming Xie et al. 1
3 Interleukin‐22 Deficiency Reduces Angiotensin II‐Induced Aortic Dissection and Abdominal Aortic Aneurysm in ApoE‐/‐ Mice Oxidative Medicine and Cellular Longevity Yuan Wang, Yulin Xu et al. 1
4 Ceramide kinase mediates intrinsic resistance and inferior response to chemotherapy in triple‐negative breast cancer by upregulating Ras/ERK and PI3K/Akt pathways Cancer Cell International Shan Zhu, Yulin Xu et al. 19
5 Interleukin-6 knockout reverses macrophage differentiation imbalance and alleviates cardiac dysfunction in aging mice Aging Yuan Wang, Shan Zhu et al. 12
6 Galeterone sensitizes breast cancer to chemotherapy via targeting MNK/eIF4E and β-catenin Cancer Chemotherapy and Pharmacology Yulin Xu, Shichong Liao et al. 13
7 Thyroxine Alleviates Energy Failure, Prevents Myocardial Cell Apoptosis, and Protects against Doxorubicin-Induced Cardiac Injury and Cardiac Dysfunction via the LKB1/AMPK/mTOR Axis in Mice Disease Markers Yuan Wang, Shan Zhu et al. 11
8 Thyroxine Affects Lipopolysaccharide-Induced Macrophage Differentiation and Myocardial Cell Apoptosis via the NF-κB p65 Pathway Both In Vitro and In Vivo Mediators of Inflammation Shan Zhu, Yuan Wang et al. 13
9 Outcomes of patients with inflammatory breast cancer by hormone receptor- and HER2-defined molecular subtypes: A population-based study from the SEER program Oncotarget Juanjuan Li, Yue Xia et al. 39
10 Breast cancer subtypes predict the preferential site of distant metastases: a SEER based study Oncotarget Qi Wu, Juanjuan Li et al. 246
11 Poorer breast cancer survival outcomes in males than females might be attributable to tumor subtype Oncotarget Qi Wu, Juanjuan Li et al. 13
12 Characteristics of breast cancer in Central China, literature review and comparison with USA The Breast Chuang Chen, Si Sun et al. 42
13 Breast carcinoma in situ: An observational study of tumor subtype, treatment and outcomes Oncotarget Qi Wu, Juanjuan Li et al. 9
14 Clinical and sonographic assessment of cervical lymph node metastasis in papillary thyroid carcinoma Journal of Huazhong University of Science and Technology [Medical Sciences] Qi Wu, Yimin Zhang et al. 9
15 Associations and indications of Ki67 expression with clinicopathological parameters and molecular subtypes in invasive breast cancer: A population-based study Oncology Letters Chuang Chen, Wen Wei et al. 18
16 Clinical pathological characteristics of breast cancer patients with secondary diabetes after systemic therapy: a retrospective multicenter study Tumor Biology Juanjuan Li, Wen Wei et al. 15
17 Immunomagnetic Reduction Assay on Des-Gamma-Carboxy Prothrombin for Screening of Hepatocellular Carcinoma IEEE Transactions on Biomedical Engineering Jen-Jie Chieh, Kai‐Wen Huang et al. 9
18 Tunicamycin-induced ER stress regulates chemokine CCL5 expression and secretion via STAT3 followed by decreased transmigration of MCF-7 breast cancer cells Oncology Reports Yimin Zhang, Shichong Liao et al. 18
19 Sonographically Guided Vacuum-Assisted Breast Biopsy for Complete Excision of Presumed Benign Breast Lesions Journal of Ultrasound in Medicine Feng Yao, Juanjuan Li et al. 21
20 [Comparison of microendoscopic discectomy with open discectomy for degenerative lumbar spinal stenosis]. PubMed Hao Peng, Wen Wei et al. 2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026